Skip to main content
Download PDF
- Main
A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery
- Hays, Ron D;
- Tarver, Michelle E;
- Eydelman, Malvina;
- Spaeth, George L;
- Parke, David W;
- Singh, Kuldev;
- Nguyen, Don;
- Saltzmann, Robert M;
- Smith, Oluwatosin;
- Shaw, My Le;
- Rosenberg, Lisa;
- Seibold, Leo;
- Teymoorian, Savak;
- Provencher, Lorraine M;
- Bicket, Amanda K;
- Arora, Nitika;
- Junk, Anna K;
- Chaya, Craig;
- Salim, Sarwat;
- Kuo, Debbie;
- Weiner, Asher;
- Zhang, Ze;
- Rhee, Brian Francis Douglas;
- McMillan, Brian;
- Choo, Clara;
- Garris, Winston;
- Noecker, Rob;
- Fellman, Ronald;
- Caprioli, Joseph;
- Vold, Steven;
- Pasquale, Louis;
- Cui, Qi;
- Mbagwu, Michael
- et al.
Published Web Location
https://doi.org/10.1016/j.ajo.2024.05.031Abstract
Purpose
To develop a patient-reported outcome measure to assess the impact of glaucoma and treatment, including minimally invasive glaucoma surgery (MIGS).Design
Observational study before and after concomitant cataract and Food and Drug Administration-approved implantable MIGS device surgery.Setting
Survey administration was on a computer, iPad, or similar device.Patient population
184 adults completed the baseline survey, 124 a survey 3 months after surgery, and 106 the 1-month test-retest reliability survey. The age range was 37 to 89 (average age = 72). Most were female (57%), non-Hispanic White (81%), and had a college degree (56%).Main outcome measures
The Glaucoma Outcomes Survey (GOS) assesses functional limitations (27 items), vision-related symptoms (7 items), psychosocial issues (7 items), and satisfaction with microinvasive glaucoma surgery (1 item). These multiple-item scales were scored on a 0 to 100 range, with a higher score indicating worse health.Results
Internal consistency reliability estimates ranged from 0.75 to 0.93, and 1-month test-retest intraclass correlations ranged from 0.83 to 0.92 for the GOS scales. Product-moment correlations among the scales ranged from 0.56 to 0.60. Improvement in visual acuity in the study eye from baseline to the 3-month follow-up was significantly related to improvements in GOS functional limitations (r = 0.18, P = .0485), vision-related symptoms (r = 0.19, P = .0386), and psychosocial concerns (r = 0.18, P = .0503). Responders to treatment ranged from 17% for vision-related symptoms to 48% for functional limitations.Conclusions
This study supports using the GOS for ophthalmic procedures such as MIGS. Further evaluation of the GOS in different patient subgroups and clinical settings is needed.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%